Why Uric Acid Increases in Pregnancy-Induced Hypertension
Uric acid increases in pregnancy-induced hypertension (PIH) through two primary mechanisms: decreased renal clearance due to kidney dysfunction and increased production from placental ischemia, trophoblast breakdown, and systemic inflammation.
Pathophysiologic Mechanisms
Decreased Renal Clearance
The kidneys in PIH undergo significant pathologic changes that impair uric acid excretion. The renal dysfunction characteristic of preeclampsia—a severe form of PIH—reduces the kidney's ability to clear uric acid from the bloodstream. This was historically considered the sole mechanism but is now understood to be only part of the picture 1.
Increased Uric Acid Production
More recent evidence demonstrates that uric acid levels rise not just from reduced clearance but from increased production through several pathways 2:
- Placental ischemia and trophoblast breakdown: The placental insufficiency that characterizes PIH leads to tissue breakdown and release of purines, which are metabolized to uric acid
- Cytokine release: The systemic inflammatory state in PIH triggers cytokine-mediated increases in uric acid production
- Oxidative stress: Tissue ischemia generates increased purine metabolism
Clinical Significance
Elevated gestation-corrected uric acid levels are associated with worse maternal and fetal outcomes and should prompt detailed assessment of fetal growth, even in women with gestational hypertension 1. However, the ISSHP guidelines explicitly state that uric acid should not be used to determine timing of delivery 1.
Prognostic Value
While uric acid is not a diagnostic criterion for preeclampsia, its levels:
- Generally correlate with disease severity 2, 3
- Predict progression from gestational hypertension to preeclampsia 4
- Associate with increased risk of small-for-gestational-age infants 4
- Correlate with maternal complications including acute kidney injury and stroke 5, 6
Potential Pathogenic Role
Beyond being a marker, uric acid may actively contribute to the pathophysiology of PIH through 2, 7:
- Endothelial dysfunction: Uric acid promotes endothelial damage and inflammation
- Oxidative stress: Despite also acting as an antioxidant, elevated uric acid can propagate oxidative injury
- Vascular damage: Direct effects on blood vessel function contributing to hypertension
Important Caveat
The exact role remains debated—whether uric acid is primarily a causative factor or a consequence of PIH is still unclear 8. Current evidence suggests it functions as both: a marker of disease severity and a potential contributor to pathogenesis.
Clinical Monitoring Recommendations
According to ISSHP guidelines, serum uric acid should be measured 1:
- At first diagnosis of chronic hypertension in pregnancy (baseline)
- At minimum twice weekly in women with preeclampsia
- At 28 and 34 weeks in gestational hypertension
- When suspicion arises of superimposed preeclampsia
The key clinical action: Elevated uric acid should trigger enhanced fetal surveillance, particularly growth assessments, but should not independently drive delivery decisions 1.